Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEV.L Regulatory News (DEV)

  • There is currently no data for DEV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Appointment of Joint Broker

19 Aug 2019 07:00

RNS Number : 4089J
Dev Clever Holdings PLC
19 August 2019
 

THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014

NOT FOR PUBLICATION OR RELEASE IN OR INTO THE UNITED STATES OR AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA, OR ANY PROVINCE OR TERRITORY THEREOF OR TO OR FOR THE ACCOUNT OF ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES OR ANY PERSON RESIDENT IN AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA.

19 August 2019

 

Dev Clever Holdings plc

("Dev Clever" or the "Company")

Placing&Appointment of Joint Broker

Dev Clever, a leading developer of consumer engagement solutions and career development platforms, is pleased to announce that the Company has today completed a placing utilising the Company's full current authorities allotting 12,811,736 new ordinary shares ("Placing Shares") of 1p each (the "Ordinary Shares") at a placing price of 3.40p (the "Placing Price") per Placing Share to raise £435,599, before expenses ("the Placing"), subject to admission to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange ("Admission"). The Placing was completed in conjunction with Novum Securities Limited ("Novum"), who have been appointed as joint broker to the Company.

The Placing Price is at a premium of 6.25% compared to the closing bid price per Ordinary Share of 3.20p, on 16 August 2019, the last trading day prior to this announcement. The Company intends to use the proceeds of the Placing for general working capital and towards accelerating the exploitation of its recently agreed commercial partnerships, which the directors of the Company believe will be instrumental in delivering revenue growth and taking the Company into cash flow positivity.

In connection with the Placing, the Company has agreed to grant Warrants to Novum to subscribe for 768,704 Ordinary Shares at an exercise price of 3.40p per share, conditional upon the grant by the Company's shareholders of a further authority to allot the resulting shares free of pre-emption rights. The Warrants may be exercised at any time in the period expiring on the third anniversary of Admission subject to the aforesaid authority.

The Company has made application for the 12,811,736 Placing Shares to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. Admission is expected to occur at 8:00 a.m. on Thursday, 22 August 2019. The Placing Shares will rank pari passu with the existing Ordinary Shares.

Following the issue of the Placing Shares, the Company's issued share capital will total 388,401,736 Ordinary Shares, with voting rights. Shareholders in the Company may use this figure as the denominator for the calculation, by which they would determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Commenting on the Placing, Christopher Jeffries, Chief Executive Officer and Executive Chairman, said:

"The positive response we have received from retailers and brands since the launch of our Engage gamification platform has been incredible. This Placing allows Dev Clever to advance the implementation of our expansion strategy, enabling the Company to secure senior personnel and business leadership from within the retail and Epos sector at the same time as accelerating our aggressive marketing and PR strategy. This enables us to exploit the immediate route to market opportunities provided by our existing and new commercial partnerships. We are delighted to be able to raise this capital above the current bid price value as this demonstrates the support the Company has from the investor community. The Placing fully funds our ambition for our Engage gamification channel. Dev Clever is breaking ground across all our channels and we are delighted in the level of confidence the market shares with us in the Company's products and solutions as we utilise the existing permissions to fund the business towards month on month breakeven."

 

 

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Dev Clever Holdings plc 

 

Christopher JeffriesChief Executive Officer and Executive ChairmanNicholas YdlibiFinance Director 

+44 (0) 845 459 0774 

+44 (0) 330 058 2922 

 

 

Novum Securities Limited - Joint BrokerColin Rowbury 

 

 

+44 (0) 20 7399 9400

 

Pello Capital - Joint Broker

Daniel Gee

 

 

 

+44 (0) 203 700 2534

- ANNOUNCEMENT ENDS -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEGGUUGRUPBGUR
Date   Source Headline
20th Apr 20202:06 pmRNSSecond Price Monitoring Extn
20th Apr 20202:00 pmRNSPrice Monitoring Extension
6th Apr 202011:05 amRNSSecond Price Monitoring Extn
6th Apr 202011:00 amRNSPrice Monitoring Extension
3rd Apr 20202:30 pmRNSTotal Voting Rights
26th Mar 20201:00 pmRNSResult of AGM
25th Mar 20207:00 amRNSNotice of AGM
16th Mar 202010:00 amRNSHolding(s) in Company
12th Mar 202011:06 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSAcquisition
9th Mar 20207:00 amRNSStrategy/Company/Ops Update
3rd Mar 20201:00 pmRNSHolding(s) in Company
2nd Mar 202011:12 amRNSHolding(s) in Company
2nd Mar 20207:00 amRNSNew Pilot
28th Feb 20202:05 pmRNSSecond Price Monitoring Extn
28th Feb 20202:00 pmRNSPrice Monitoring Extension
28th Feb 20201:07 pmRNSAnnual Financial Report
24th Feb 202011:06 amRNSSecond Price Monitoring Extn
24th Feb 202011:00 amRNSPrice Monitoring Extension
20th Feb 20207:00 amRNSTrading Statement
20th Feb 20207:00 amRNSTrading Statement
19th Feb 20203:20 pmRNSHolding(s) in Company
12th Feb 202011:00 amRNSPrice Monitoring Extension
5th Feb 20204:41 pmRNSSecond Price Monitoring Extn
5th Feb 20204:35 pmRNSPrice Monitoring Extension
5th Feb 20207:00 amRNSHolding(s) in Company
31st Jan 202011:15 amRNSHolding(s) in Company
31st Jan 20207:01 amRNSTotal Voting Rights
31st Jan 20207:00 amRNSHolding(s) in Company
30th Jan 20202:06 pmRNSSecond Price Monitoring Extn
30th Jan 20202:00 pmRNSPrice Monitoring Extension
24th Jan 20207:01 amRNSDirector/PDMR Shareholding
24th Jan 20207:00 amRNSHolding(s) in Company
22nd Jan 20207:01 amRNSDirector/PDMR Shareholding
22nd Jan 20207:00 amRNSHolding(s) in Company
20th Jan 202012:00 pmRNSGM Statement
23rd Dec 20194:12 pmRNSHolding(s) in Company
23rd Dec 20192:00 pmRNSNotice of GM
20th Dec 20193:19 pmRNSHolding(s) in Company
20th Dec 20197:00 amRNSPlacing
19th Dec 20193:15 pmRNSStmnt re Share Price Movement
19th Dec 20191:34 pmRNSHolding(s) in Company
28th Oct 20197:00 amRNSStrategy update: Educate Platform
26th Sep 20197:00 amRNSCommercial Agreement
6th Sep 20197:00 amRNSNew Appointment
30th Aug 20197:00 amRNSTotal Voting Rights
29th Aug 20197:00 amRNSContract
21st Aug 201911:05 amRNSSecond Price Monitoring Extn
21st Aug 201911:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.